EverGlade Consulting hires Joe Larsen as managing director
EverGlade Consulting, a management consultancy focusing on federal contractors, has hired Joe Larsen, PhD, as a managing director.
Based in Arlington, VA, Larsen brings over two decades of private and public sector experience in biomedical research and healthcare policy.
Before joining EverGlade, he spent five years at biotech firms developing drugs for the treatment of antibiotic-resistant bacteria. Larsen was VP of clinical development at Locus Biosciences and VP for strategic portfolio development at Venatorx Pharmaceuticals.
Prior to that, Larsen held several leadership roles at the Biomedical Advanced Research and Development Authority (BARDA), including serving as deputy director of the division of CBRN medical countermeasures. In the role, Larsen helped lead strategic planning and execution of BARDA’s advanced research and development funding. He also developed strategies to prepare for and respond to mass public health emergencies involving chemical, biological, radiological, and nuclear threats.
Larsen has a doctorate in microbiology and immunology from the Uniformed Services University of the Health Sciences and a bachelor’s degree from the University of Kansas.
“I look forward to providing strategic leadership within Everglade to ensure we remain committed to providing high quality technical, financial, and program management services for our clients and delivering the value they expect,” Larsen said.
Eric Jia-Sobota, founder and consulting leader of EverGlade, added, "I am thrilled to welcome Joe to the team, and know he will be able to enhance the expertise available to our clients."
Founded in 2020 and headquartered in Houston, EverGlade helps government contractors secure non-dilutive federal funding. The firm’s services range from initial proposal support through to compliance with various regulatory frameworks.
EverGlade works with clients in life sciences, healthcare, non-profit, and construction. The firm has more than 20 professionals, according to LinkedIn.